title: Meeting the need for regenerative therapies I: target-based incidence and its relationship to U.S. spending, productivity, and innovation.
abstract: Regenerative therapies possess high theoretical potential for medical advance yet their success as commercial therapeutics is still open to debate. Appropriate data on target opportunities that provide perspective and enable strategic decision making is necessary for both efficient and effective translation. Up until now, this data have been out of reach to research scientists and many start-up companies-the very groups currently looked to for the critical advance of these therapies. The target-based estimate of opportunity presented in this report demonstrates its importance in evaluating medical need and technology feasibility. In addition, analysis of U.S. research spending, productivity, and innovation reveals that U.S. basic research in this field would benefit from greater interdisciplinarity. Overcoming the barriers that currently prevent translation into high value therapies that are quickly clinically adopted requires simultaneous integration of engineering, science, business, and clinical practice. Achieving this integration is nontrivial.
authors: Parenteau BioConsultants , LLC, Fair Haven, Vermont, USA.
authors: Nancy
authors: N
authors: Parenteau
authors: Janet
authors: J
authors: Hardin-Young
authors: William
authors: W
authors: Shannon
authors: Patrick
authors: P
authors: Cantini
authors: Alan
authors: A
authors: Russell
mesh_terms: D035843:Biomedical Research / Q000191:economics; D004194:Disease; D004526:Efficiency; D006801:Humans; D007449:Investments / Q000191:economics; D009316:National Institutes of Health (U.S.); D009936:Organizational Innovation / Q000191:economics; D044968:Regenerative Medicine / Q000191:economics* / Q000458:organization & administration*; D057905:Stem Cell Research / Q000191:economics; D018581:Technology Transfer; D023822:Tissue Engineering / Q000191:economics; D014481:United States